Display options
Share it on
Full text links
Silverchair Information Systems Free PMC Article

J Exp Med. 1992 Jun 01;175(6):1663-8. doi: 10.1084/jem.175.6.1663.

T cell recognition of self-human histocompatibility leukocyte antigens (HLA)-DR peptides in context of syngeneic HLA-DR molecules.

The Journal of experimental medicine

Z Liu, Y K Sun, Y P Xi, P Harris, N Suciu-Foca

Affiliations

  1. College of Physicians & Surgeons, Columbia University, Department of Pathology, New York, New York 10032.

PMID: 1375267 PMCID: PMC2119255 DOI: 10.1084/jem.175.6.1663
Free PMC Article

Abstract

It has been suggested that self major histocompatibility complex (MHC) peptides bound to self MHC molecules may be involved in the intrathymic induction of self tolerance. We studied the antigenicity of synthetic peptides derived from the first domain of DR beta 1*0101 chain in a DR beta 1*0101 responder. We found that a peptide corresponding to residues 21-42 of the beta chain could elicit the proliferation of autoreactive T cells. A T cell line (TCL-SUN) and 7 of 9 T cell clones (TCC) derived from TCL-SUN specifically recognized peptide 21-42 in the presence of APCs carrying the DR beta 1*0101 allele. DR beta 1*0101 positive APCs stimulated the TCCs in the absence of peptide, although the magnitude of the response was much lower than in cultures with peptide. This suggests that self DR1 molecules are continuously processed into peptides that are presented by the DR1 molecules on the surface of the cells. The data indicate that some T cells whose TCR binds to self MHC peptides presented by self MHC molecules are not deleted, although their ligand is continuously present. TCCs specific for peptide 21-42 presented in the context of DR1 were also stimulated by cells heterozygous for DR beta 1*0301 and 1601, indicating that some DR peptide-specific autoreactive T cells participate in alloreactivity.

Similar articles

Ahuja P.
J Oral Maxillofac Pathol. 2018 Jan-Apr;22(1):4-5. doi: 10.4103/jomfp.JOMFP_58_18.
PMID: 29731548

Gutierrez-Hoffmann MG, O'Meally RN, Cole RN, Tiniakou E, Darrah E, Soloski MJ.
Front Med (Lausanne). 2020 Sep 16;7:568. doi: 10.3389/fmed.2020.00568. eCollection 2020.
PMID: 33043033

References

  1. J Immunol. 1992 Jan 1;148(1):35-40 - PubMed
  2. Eur J Biochem. 1980 Jun;107(2):303-14 - PubMed
  3. Science. 1990 Dec 21;250(4988):1720-3 - PubMed
  4. Science. 1990 Mar 30;247(4950):1587-9 - PubMed
  5. Nature. 1989 Apr 27;338(6218):765-8 - PubMed
  6. Proc Natl Acad Sci U S A. 1989 Jun;86(11):4190-4 - PubMed
  7. Proc Natl Acad Sci U S A. 1987 Sep;84(17):6234-8 - PubMed
  8. Nature. 1985 Sep 26-Oct 2;317(6035):359-61 - PubMed
  9. Nature. 1991 Oct 17;353(6345):622-7 - PubMed
  10. Nature. 1991 Oct 17;353(6345):660-2 - PubMed
  11. J Exp Med. 1990 Nov 1;172(5):1341-6 - PubMed
  12. J Exp Med. 1990 Sep 1;172(3):779-88 - PubMed
  13. Proc Natl Acad Sci U S A. 1990 Mar;87(5):1762-6 - PubMed
  14. Cell. 1990 Mar 23;60(6):1043-53 - PubMed
  15. Cell. 1986 Mar 28;44(6):959-68 - PubMed
  16. Nature. 1989 Nov 9;342(6246):183-5 - PubMed
  17. Proc Natl Acad Sci U S A. 1989 Nov;86(22):8941-5 - PubMed
  18. J Exp Med. 1989 Mar 1;169(3):1191-6 - PubMed
  19. Proc Natl Acad Sci U S A. 1987 May;84(10):3400-4 - PubMed
  20. Annu Rev Biochem. 1970;39:841-66 - PubMed
  21. Immunol Today. 1991 Jun;12(6):175-7 - PubMed

Substances

MeSH terms

Publication Types

Grant support

LinkOut - more resources